Sowell Financial Services LLC Incyte Corp Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$79.87 - $87.53 $10,702 - $11,729	-134 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$76.02 - $100.5 $3,877 - $5,125	-51 Reduced 27.57%	134 $11,000
Q4 2020 Jan 13, 2021	SELL	$80.74 - $97.7 $15,421 - $18,660	-191 Reduced 50.8%	185 $16,000
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $170 - $219	-2 Reduced 0.53%	376 $34,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $1,112 - $1,633	15 Added 4.13%	378 $39,000
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $283,172 - $385,317	-4,482 Reduced 92.51%	363 $27,000
Q4 2019 Feb 07, 2020	BUY	$73.04 - $95.72 $349,350 - $457,828	4,783 Added 7714.52%	4,845 $0
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $4,514 - $5,364	62 New	62 $5,000

652

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.